$185.382,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

This issue of Hematology/Oncology Clinics, guest edited by Andrew A. Lane, will cover Blastic Plasmacytoid Dendritic Cell Neoplasm. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue include: Clinical Presentation and Pathology, Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA mutations and epigenetics, Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm Chemotherapy, CD123 and Leukemia Stem Cells, Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm, Immune Therapies Targeting CD123 in Blastic Plasmacytoid Dendritic Cell Neoplasm, Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, European Perspective, Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm, and Social Media in Blastic Plasmacytoid Dendritic Cell Neoplasm and Other Rare Diseases.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis - p. 491 8. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective - p. 501 9. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics - p. 511 10. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations - p. 523 11. Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 539 12. CD123 as a Therapeutic Target Against Malignant Stem Cells - p. 553 13. Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 565 14. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 575 15. Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 589 16. Blastic Plasmacytoid Dendritic Cell Neoplasm in Children - p. 601 17. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective - p. 613 18. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 621

Descripcion
Descripción

This issue of Hematology/Oncology Clinics, guest edited by Andrew A. Lane, will cover Blastic Plasmacytoid Dendritic Cell Neoplasm. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue include: Clinical Presentation and Pathology, Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA mutations and epigenetics, Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm Chemotherapy, CD123 and Leukemia Stem Cells, Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm, Immune Therapies Targeting CD123 in Blastic Plasmacytoid Dendritic Cell Neoplasm, Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, European Perspective, Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm, and Social Media in Blastic Plasmacytoid Dendritic Cell Neoplasm and Other Rare Diseases.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis - p. 491 8. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective - p. 501 9. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics - p. 511 10. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations - p. 523 11. Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 539 12. CD123 as a Therapeutic Target Against Malignant Stem Cells - p. 553 13. Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 565 14. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 575 15. Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 589 16. Blastic Plasmacytoid Dendritic Cell Neoplasm in Children - p. 601 17. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective - p. 613 18. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 621

Indice
Autores
Muestra
Ficha Técnica